Search
Patexia Research
Case number 1:18-cv-00464

Takeda Pharmaceuticals U.S.A., Inc. v. Zydus Pharmaceuticals (USA) Inc. et al > Documents

Date Field Doc. No.Description (Pages)
Oct 12, 2018 20 Main Document (2)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,906,519; 7,935,731; 8,093,298; 7,964,648; 8,093,297; US 7,619,004; US 7,601,758; US 7,820,681; US 7,915,269; US 7,964,647; US 7,981,938; US 9,093,296; US 8,097,655; US 8,415,395; US 8,415,396; US 8,440,721; US 8,440,722. (Attachments: # (1) Order)(nms)
Oct 12, 2018 20 Order (2)
Oct 12, 2018 20 Patent/Trademark Report to Commissioner (2)
Oct 12, 2018 19 Order (2)
Docket Text: SO ORDERED Granting [18] Stipulation of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 10/11/2018. (nms)
Oct 11, 2018 18 Stipulation of Dismissal (2)
Docket Text: STIPULATION of Dismissal Without Prejudice, by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) Modified on 10/11/2018 (nms).
Aug 27, 2018 17 Order (3)
Docket Text: SO ORDERED Granting [16] Stipulation and Order to Stay Action Pending Regulatory Review of Settlement. Signed by Judge Richard G. Andrews on 8/27/2018. (nms)
Aug 27, 2018 16 Stipulation (3)
Docket Text: STIPULATION and Proposed Order to Stay Action Pending Regulatory Review of Settlement by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel)
Aug 14, 2018 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [15] STIPULATION TO EXTEND TIME To Answer, Move or Otherwise Respond to the Complaint to August 27, 2018 (*Reset Answer Deadlines: Cadila Healthcare Limited answer due 8/27/2018; Zydus Pharmaceuticals (USA) Inc. answer due 8/27/2018). Signed by Judge Richard G. Andrews on 8/14/2018. (nms)
Aug 13, 2018 15 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME To Answer, Move or Otherwise Respond to the Complaint to August 27, 2018 - filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc.. (Phillips, John)
Aug 6, 2018 14 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to answer, plead or otherwise respond to the Complaint to August 13, 2018 - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel)
Aug 6, 2018 N/A SO ORDERED (0)
Jul 23, 2018 N/A SO ORDERED (0)
Jul 20, 2018 13 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to Answer, Plead or Otherwise respond to the Complaint to August 6, 2018 - filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc.. (Phillips, John)
Jul 10, 2018 N/A SO ORDERED (0)
Jul 9, 2018 12 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to answer, plead or otherwise respond to the Complaint to July 23, 2018 - filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc.. (Phillips, John)
Jun 22, 2018 N/A SO ORDERED (0)
Jun 21, 2018 11 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to Answer, Plead or Otherwise Respond to the Complaint to July 9, 2018 - filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc.. (Phillips, John)
Apr 5, 2018 N/A SO ORDERED (0)
Apr 4, 2018 10 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to June 25, 2018 - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel)
Apr 4, 2018 9 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by David A. Bilson on behalf of Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc. (Bilson, David)
Apr 4, 2018 8 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by John C. Phillips, Jr on behalf of Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc. (Phillips, John)
Mar 30, 2018 7 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by Takeda Pharmaceuticals U.S.A., Inc.: For Cadila Healthcare Limited waiver sent on 3/27/2018, answer due 6/25/2018. (Attaway, Daniel)
Mar 30, 2018 6 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by Takeda Pharmaceuticals U.S.A., Inc.: For Zydus Pharmaceuticals (USA) Inc. waiver sent on 3/27/2018, answer due 5/29/2018. (Attaway, Daniel)
Mar 28, 2018 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
Mar 27, 2018 3 ANDA Form (2)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/19/02018. Date of Expiration of Patent: 12/3/2028. Thirty Month Stay Deadline: 8/19/2020. (lmm)
Mar 27, 2018 4 Patent/Trademark Report to Commissioner (2)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,906,519; 7,935,731; 8,093,298; 7,964,648; 8,093,297.(lmm)
Mar 27, 2018 5 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceutical Company Limited, Corporate Parent Takeda Pharmaceuticals International AG for Takeda Pharmaceuticals U.S.A., Inc. filed by Takeda Pharmaceuticals U.S.A., Inc. (lmm)
Mar 27, 2018 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lmm)
Mar 27, 2018 1 Civil Cover Sheet (2)
Mar 27, 2018 1 Exhibit S (26)
Mar 27, 2018 1 Exhibit R (27)
Mar 27, 2018 1 Exhibit Q (31)
Mar 27, 2018 1 Exhibit P (31)
Mar 27, 2018 1 Exhibit O (19)
Mar 27, 2018 1 Exhibit N (19)
Mar 27, 2018 1 Exhibit M (35)
Mar 27, 2018 1 Exhibit L (36)
Mar 27, 2018 1 Exhibit K (28)
Mar 27, 2018 1 Exhibit J (26)
Mar 27, 2018 1 Exhibit I (16)
Mar 27, 2018 1 Exhibit H (16)
Mar 27, 2018 1 Exhibit G (27)
Mar 27, 2018 1 Exhibit F (29)
Mar 27, 2018 1 Exhibit E (19)
Mar 27, 2018 1 Exhibit D (16)
Mar 27, 2018 1 Exhibit C (23)
Mar 27, 2018 1 Exhibit B (16)
Mar 27, 2018 1 Exhibit A (25)
Mar 27, 2018 1 Complaint (34)
Mar 27, 2018 N/A CORRECTING ENTRY: (0)
Docket Text: CORRECTING ENTRY: Please see list attached at D.I. [4] which includes additional patent/trademark numbers. (lmm) Modified on 3/29/2018 (nms).
Mar 27, 2018 1 Main Document (34)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2349001.) - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Civil Cover Sheet)(lmm).
Mar 27, 2018 N/A Summons Issued (0)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Cadila Healthcare Limited on 3/27/2018; Zydus Pharmaceuticals (USA) Inc. on 3/27/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (lmm)
Mar 27, 2018 1 Complaint* (1)
Menu